cinchocaine

Trade name: nupercaine

Small moleculeapproved

Dibucaine is used as a local anesthetic for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. Dibucaine is used to temporarily relieve pain and itching due to: hemorrhoids or other anorectal disorders, sunburn, minor burns, minor cuts; scrapes, insect bites, minor skin irritation. This drug acts via blocking of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions through sodium channel blocking. This reversibly stabilizes the membrane and inhibits depolarization, resulting in the failure of a propagated action potential and subsequent conduction blockade. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 2 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1930s

  1. Jun 1, 1930

    Ciba — First NDA Organization

  2. Jun 1, 1930

    Ciba — NDA Organization

Indications

Mechanism of action

Approval history

  • approved

Chemistry & pharmacology

Loading structure…

SMILES

CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
Mol. weight
343.47 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Discontinued

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • 2-butoxy-n-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
  • 2-butoxy-n-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
  • 2-butoxy-n-(2-(diethylamino)ethyl)cinchoninamide
  • 2-butoxy-n-(2-(diethylamino)ethyl)cinchoninamide
  • 2-butoxy-n-(alpha-diethylaminoethyl)cinchoninamide
  • 2-butoxy-n-(alpha-diethylaminoethyl)cinchoninamide
  • 2-butoxy-n-(beta-diethylaminoethyl)cinchoninamide
  • 2-butoxy-n-(beta-diethylaminoethyl)cinchoninamide
  • 2-butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide
  • 2-butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide
  • 2-butoxyquinoline-4-carboxylic acid diethylaminoethylamide
  • 2-butoxyquinoline-4-carboxylic acid diethylaminoethylamide
  • 2-n-butoxy-n-(2-diethylaminoethyl)cinchoninamide
  • 2-n-butoxy-n-(2-diethylaminoethyl)cinchoninamide
  • alpha-butyloxycinchonic acid-gamma-diethylethylenediamine
  • alpha-butyloxycinchonic acid-gamma-diethylethylenediamine
  • alpha-butyloxycinchoninic acid diethylethylenediamide
  • alpha-butyloxycinchoninic acid diethylethylenediamide
  • cincaine chloride
  • cincaine chloride
  • cinchocaine
  • cinchocaine
  • cinchocaine
  • cinchocaine
  • cinchocaine
  • cinchocaine
  • cinchocaine
  • cinchocaine
  • cinchocaine hcl
  • cinchocaine hcl
  • cinchocainum
  • cinchocainum
  • cincocainio
  • cincocainio
  • dermacaine
  • dibucaine
  • dibucaine
  • dibucaine
  • dibucaine
  • dibucaine
  • dibucaine
  • dibucaine base
  • dibucaine base
  • dibucaine hcl
  • dibucaine hcl
  • dibucaine hcl
  • dibucaine hydrochloride
  • dibucaine hydrochloride
  • dibucaine hydrochloride
  • dibucaine hydrochloride
  • heavy solution nupercaine
  • heavy solution nupercaine
  • n-(2-(diethylamino)ethyl)-2-butoxycinchoninamide
  • n-(2-(diethylamino)ethyl)-2-butoxycinchoninamide
  • nupercainal
  • nupercainal
  • nupercaine
  • nupercaine
  • nupercaine
  • nupercaine
  • percamine

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
CibaFor profitNDAJun 1, 1930
NovartisFor profitNDA2